GLP-1 receptor agonists — the glucagon-like peptide-1 mimetics that have transformed metabolic disease treatment through glucose-dependent insulin secretion enhancement, glucagon suppression, gastric motility reduction, and profound appetite suppression — represent the most commercially significant pharmaceutical class launched in the past decade, with the GLP-1 Drug Market...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china